359 related articles for article (PubMed ID: 26344637)
41. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
[TBL] [Abstract][Full Text] [Related]
42. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
43. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description.
Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF
Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337
[TBL] [Abstract][Full Text] [Related]
44. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
Pacheco MC; Dolan M; Bendel A
Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
[TBL] [Abstract][Full Text] [Related]
46. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
[TBL] [Abstract][Full Text] [Related]
47. Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain.
Bruggers CS; Moore K
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e341-5. PubMed ID: 24072251
[TBL] [Abstract][Full Text] [Related]
48. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
49. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
50. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.
Chakravadhanula M; Ozols VV; Hampton CN; Zhou L; Catchpoole D; Bhardwaj RD
Cancer Genet; 2014 Sep; 207(9):425-8. PubMed ID: 25085602
[TBL] [Abstract][Full Text] [Related]
51. Detection of an atypical teratoid rhabdoid brain tumor gene deletion in circulating blood using next-generation sequencing.
Chakravadhanula M; Tembe W; Legendre C; Carpentieri D; Liang WS; Bussey KJ; Carpten J; Berens ME; Bhardwaj RD
J Child Neurol; 2014 Sep; 29(9):NP81-5. PubMed ID: 24141276
[TBL] [Abstract][Full Text] [Related]
52. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
53. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
Al-Hussaini M; Hirschowitz L; McCluggage WG
Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
55. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
56. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
Packer RJ; Biegel JA; Blaney S; Finlay J; Geyer JR; Heideman R; Hilden J; Janss AJ; Kun L; Vezina G; Rorke LB; Smith M
J Pediatr Hematol Oncol; 2002; 24(5):337-42. PubMed ID: 12142780
[TBL] [Abstract][Full Text] [Related]
57. Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization.
Kleinschmidt-DeMasters BK; Birks DK; Aisner DL; Hankinson TC; Rosenblum MK
Am J Surg Pathol; 2011 Dec; 35(12):1894-901. PubMed ID: 22082607
[TBL] [Abstract][Full Text] [Related]
58. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
[TBL] [Abstract][Full Text] [Related]
59. SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression.
Masliah-Planchon J; Machet MC; Fréneaux P; Jourdain A; Mortemousque I; Raïs KA; Ballet S; Jouvet A; Figarella-Branger D; Delattre O; Bourdeaut F
Pediatr Blood Cancer; 2016 Mar; 63(3):568-9. PubMed ID: 26469284
[No Abstract] [Full Text] [Related]
60. Investigation of the location of atypical teratoid/rhabdoid tumor.
Dho YS; Kim SK; Cheon JE; Park SH; Wang KC; Lee JY; Phi JH
Childs Nerv Syst; 2015 Aug; 31(8):1305-11. PubMed ID: 25953096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
